Quality of life after Rectal Cancer Treatment

Summary

We want to understand patient's experiences, perspectives and preference with locally advanced rectal cancer treatment in Alberta. Our study looks at patients with locally advanced rectal cancer (stage II/III), who are often treated first with chemotherapy and radiation, in what is called "total neoadjuvant treatment" or "TNT".

After TNT patients either receive surgery, or select patients undergo a non operative "watch and wait" strategy. Our study looks at the quality of life perspective. We want to know from patients how their experience was, and what their priorities and perceptions are. In addition, we want to understand how the treatment impacts their quality of life, and their bowel, bladder and sexual function.

We are doing online one-on-one interviews for patients to be able to provide the patient perspective on their treatment experience and side effects.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Inclusion criteria:

1. New diagnosis of rectal cancer undergoing chemotherapy and radiation
2. At least age 18

Exclusion criteria:

You are not eligible to participate if you do not live in Alberta or if you are under the age of 18.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

Christine Wang

Principal investigator:

Tamara Gimon

Clinical trial:

No

REB-ID:

HREBA.CC-23-0020